Physician profile
David Jacobs
NPI 1184675100
$3,812.57
in general payments reported to CMS, 2019-2025
18 companies · $1,206 in 2025
The $1,206 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $215 · 2022: $760 · 2023: $1,021 · 2024: $611 · 2025: $1,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,837.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $787.16 | 2022-2025 | |
| Notal Vision, INC. | $553.71 | 2022-2025 | Foresee Home |
| Halozyme INC | $379.89 | 2025 | Hylenex Recombinant |
| Genentech USA, INC. | $362.01 | 2022-2025 | Vabysmo |
| Alimera Sciences, INC. | $326.13 | 2022-2024 | Iluvien, Yutiq |
| Regeneron Healthcare Solutions, INC. | $283.82 | 2021-2025 | Eylea Hd, Eylea |
| Genentech, INC. | $210.38 | 2023 | Vabysmo |
| Allergan, INC. | $181.42 | 2021 | |
| Mallinckrodt Hospital Products INC. | $180.26 | 2023-2024 | Acthar |
| Apellis Pharmaceuticals, INC. | $147.54 | 2023 | Syfovre |
| Astellas Pharma US INC | $112.00 | 2024-2025 | Izervay |
| Bausch & Lomb Americas INC. | $89.99 | 2023-2025 | Xipere |
| Alcon Vision LLC | $69.82 | 2023-2025 | Clareon, Clareon Panoptix Pro |
| Harrow Eye, LLC | $38.34 | 2024-2025 | Vevye, Triesence |
| Ani Pharmaceuticals, INC. | $36.46 | 2025 | Iluvien, Purified Cortrophin Gel |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $18.74 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $17.88 | 2024 | |
| Novartis Pharmaceuticals Corporation | $17.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.